ibuprofen has been researched along with Hemolysis in 11 studies
Midol: combination of cinnamedrine, phenacetin, aspirin & caffeine
Hemolysis: The destruction of ERYTHROCYTES by many different causal agents such as antibodies, bacteria, chemicals, temperature, and changes in tonicity.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ibuprofen is included on websites and frequently referenced lists as medium risk for inducing hemolysis in children with glucose-6-phosphate dehydrogenase (G6PD) deficiency." | 5.22 | Safety of Ibuprofen in Children With G6PD Deficiency: A Systematic Review. ( Chandar, A; Isaacson, G; Pankey, AN, 2022) |
| " PP-g-(NIPAAm-r-APMA) films showed temperature-responsive swelling, smaller friction coefficients, hemolysis and thrombogenicity and higher cell compatibility, did not elicit secretion of cytokines, and took up remarkable amounts of diclofenac and ibuprofen and sustained delivery for several hours in phosphate buffer, pH 7." | 3.77 | Stimuli-responsive networks grafted onto polypropylene for the sustained delivery of NSAIDs. ( Alvarez-Lorenzo, C; Bucio, E; Concheiro, A; Contreras-García, A; Taboada, C, 2011) |
| " Eight NSAID (carprofen, diclofenac, ibuprofen, ketoprofen, naproxen, piroxicam, phenylbutazone, tiaprofenic acid) were assessed in a photohemolysis test for phototoxic effects in the visible light range." | 3.69 | Phototoxicity of non-steroidal anti-inflammatory drugs: in vitro studies with visible light. ( Becker, L; Eberlein-König, B; Przybilla, B, 1996) |
| "Oleanolic acid is a naturally occurring compound, isolated from Luffa cylindrica, which inhibits the in-vitro immunohaemolysis of antibody-coated sheep erythrocytes by guinea-pig serum." | 1.29 | Anti-complement activity of oleanolic acid: an inhibitor of C3-convertase of the classical complement pathway. ( Kapil, A; Sharma, S, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (9.09) | 18.7374 |
| 1990's | 3 (27.27) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 3 (27.27) | 24.3611 |
| 2020's | 3 (27.27) | 2.80 |
| Authors | Studies |
|---|---|
| Pankey, AN | 1 |
| Chandar, A | 1 |
| Isaacson, G | 1 |
| Bauer-Rusek, S | 1 |
| Samra, N | 1 |
| Moore, SS | 1 |
| Arnon, S | 1 |
| Strimaite, M | 1 |
| Harman, CLG | 1 |
| Duan, H | 1 |
| Wang, Y | 1 |
| Davies, GL | 1 |
| Williams, GR | 1 |
| Kameshwar, VH | 1 |
| R, KJ | 1 |
| Priya, BS | 1 |
| Swamy, SN | 1 |
| Contreras-García, A | 1 |
| Alvarez-Lorenzo, C | 1 |
| Taboada, C | 1 |
| Concheiro, A | 1 |
| Bucio, E | 1 |
| Ghassabian, S | 1 |
| Wright, LA | 1 |
| Dejager, AD | 1 |
| Smith, MT | 1 |
| Baydoun, L | 1 |
| Düvel, A | 1 |
| Daniels, R | 1 |
| Drust, A | 1 |
| Goldhagen, T | 1 |
| Schwan, I | 1 |
| Zeidler, C | 1 |
| Müller-Goymann, CC | 1 |
| Raghava, GP | 1 |
| Goel, A | 1 |
| Singh, AM | 1 |
| Varshney, GC | 1 |
| Kapil, A | 1 |
| Sharma, S | 1 |
| Becker, L | 1 |
| Eberlein-König, B | 1 |
| Przybilla, B | 1 |
| Castell, JV | 1 |
| Gomez, MJ | 1 |
| Miranda, MA | 1 |
| Morera, IM | 1 |
1 review available for ibuprofen and Hemolysis
| Article | Year |
|---|---|
Safety of Ibuprofen in Children With G6PD Deficiency: A Systematic Review.
Topics: Child; Glucosephosphate Dehydrogenase Deficiency; Hemolysis; Humans; Ibuprofen; Pain; Pharmaceutical | 2022 |
10 other studies available for ibuprofen and Hemolysis
| Article | Year |
|---|---|
Paracetamol Treatment for Patent Ductus Arteriosus, an Apparent Association with Acute Hemolysis in Three Preterm Infants: Case Series.
Topics: Acetaminophen; Ductus Arteriosus, Patent; Hemolysis; Humans; Ibuprofen; Infant, Newborn; Infant, Pre | 2022 |
Layered terbium hydroxides for simultaneous drug delivery and imaging.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Caco-2 Cells; Cell Survival; Diclofenac; Drug Deli | 2021 |
Synthesis, characterization and bioactivity studies of novel 1,3,4-oxadiazole small molecule that targets basic phospholipase A
Topics: Animals; Enzyme Inhibitors; Fenoprofen; Group II Phospholipases A2; Hemolysis; Ibuprofen; Male; Mice | 2017 |
Stimuli-responsive networks grafted onto polypropylene for the sustained delivery of NSAIDs.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Line; Diclofenac; Hemolysis; Humans; Ibuprofe | 2011 |
Development and validation of a sensitive solid-phase-extraction (SPE) method using high-performance liquid chromatography/tandem mass spectrometry (LC-MS/MS) for determination of risedronate concentrations in human plasma.
Topics: Acetaminophen; Chromatography, High Pressure Liquid; Diazomethane; Drug Stability; Etidronic Acid; H | 2012 |
Comparison of different ibuprofen-amino acid compounds with respect to emulsifying and cytotoxic properties.
Topics: Adult; Animals; Arginine; Cornea; Drug Combinations; Drug Stability; Emulsifying Agents; Emulsions; | 2004 |
A simple microassay for computing the hemolytic potency of drugs.
Topics: Animals; Electronic Data Processing; Erythrocytes; Flufenamic Acid; Hemolysis; Ibuprofen; Indomethac | 1994 |
Anti-complement activity of oleanolic acid: an inhibitor of C3-convertase of the classical complement pathway.
Topics: Animals; Complement C3; Complement C3-C5 Convertases; Complement Inactivator Proteins; Complement Pa | 1994 |
Phototoxicity of non-steroidal anti-inflammatory drugs: in vitro studies with visible light.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Carbazoles; Dermatitis, Phototoxic; Diclofenac; Erythrocyte | 1996 |
Photolytic degradation of ibuprofen. Toxicity of the isolated photoproducts on fibroblasts and erythrocytes.
Topics: Erythrocytes; Fibroblasts; Hemolysis; Humans; Ibuprofen; Photolysis | 1987 |